LLY-284
Ar gyfer ymchwil wyddonol yn unig, nid ar gyfer cleifion.
Manylion Cynnyrch
Tagiau Cynnyrch
| Maint Pecyn | Argaeledd | Pris (USD) |
| 0.1G | Mewn Stoc | 350 |
| 0.5G | Mewn Stoc | 750 |
| 1G | Mewn Stoc | 910 |
Enw Cemegol:
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-[(5S)-5-C-ffenyl-β-D-riboffuranosyl]-
Cod gwenu:
O[C@H]1[C@H](N2C3C(=C(N=CN=3)N)C=C2)O[C@]([H])([C@H](O) C2C=CC=CC=2)[C@H]1O
Cod InChi:
InChI=1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)1 1(22)9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12-,13+ ,14+,17+/m0/s1
Allwedd InChi:
WWOOWAHTEXIWBO-CNUKPYSBSA-N
Allweddair:
2226515-75-7 ； CAS: 2226515-75-7 ； CAS: 2226515-75-7 ；LLY-284；LLY 284；LLY284
Hydoddedd:
Storio:
Disgrifiad:
Mae LLY-283 yn atalydd effeithiol o PRMT5.
Targed: PRMT5
![3-cloro-2-(10-fflworo-8-(prop-1-yn-1-yl)-1,2,3,4,12,12a-hexahydro-6H-benso[f]pyrazino[2,1 -c][1,4]oxazepin-9-yl)ffenol](http://www.caerulumpharm.com/uploads/20240722105749.jpg)
![1H-Pyrazolo[3,4-d]pyrimidin, 6-cloro-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]ffenyl]methyl]-](http://www.caerulumpharm.com/uploads/20240603134133.jpg)
![4H-1,3-Dioxolo[4,5-c]pyrrole-4-asid carbocsilig, tetrahydro-2,2-dimethyl-6-oxo-, (3aS,4S,6aS)-](http://www.caerulumpharm.com/uploads/20241023143839.jpg)
